IMNN - Imunon, Inc.
3.24
-0.100 -3.086%
Share volume: 19,382
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$3.34
-0.10
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-14-2024 | 11-07-2024 | 02-27-2025 | 05-12-2025 | 08-05-2025 | 11-13-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 5.011 M | 5.013 M | 4.961 M | 4.146 M | 4.145 M | 2.768 M | 3.476 M | |
| Selling general and admin | 1.718 M | 2.194 M | 1.668 M | 1.913 M | 1.980 M | 1.541 M | 1.577 M | |
| Research and development | 3.294 M | 2.820 M | 3.293 M | 2.233 M | 2.165 M | 1.227 M | 1.899 M | |
| Total expenses | 5.011 M | 5.013 M | 4.961 M | 4.146 M | 4.145 M | 2.768 M | 3.476 M | |
| 0.04% | -1.03% | -16.43% | -0.02% | -33.23% | 25.58% | |||
| Operating income | -5.011 M | -5.013 M | -4.961 M | -4.146 M | -4.145 M | -2.768 M | -3.476 M | |
| Ebit | -5.011 M | -5.013 M | -4.961 M | -4.146 M | -4.145 M | -2.768 M | -3.476 M | |
| Pretax income | -4.930 M | -4.788 M | -4.845 M | -4.057 M | -4.102 M | -2.741 M | -3.429 M | |
| -2.87% | 1.20% | -16.27% | 1.12% | -33.20% | 25.12% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -4.930 M | -4.788 M | -4.845 M | -4.057 M | -4.102 M | -2.741 M | -3.429 M | |
| 2.87% | -1.20% | 16.27% | -1.12% | 33.20% | -25.12% |